The objective of this study was to investigate the relationship between FGF21 levels and anthropometric, clinical, biochemical, and echocardiographic parameters in patients diagnosed with acute coronary syndromes, with a specific focus on the correlation between FGF21 levels and the degree of obesity. This evidence concerns the gene FGF21 and obesity disorder.